MSCM
IHE icon

McElhenny Sheffield Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-202,612
Closed -$17.6M – 116
2026
Q1 		$17.6M Buy
+202,612
New +$17.7M 4.35% 5
2024
Q3 		– Sell
-285,613
Closed -$18.9M – 106
2024
Q2 		$18.9M Buy
+285,613
New +$18.7M 6.53% 5

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
SIA
SeaBridge Investment Advisors Summit, New Jersey $692M AUM 52.26% 1-Year Est. Return

McElhenny Sheffield Capital Management's IHE Position: Q2 2026 in Review

McElhenny Sheffield Capital Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2026, closing a stake of 202,612 shares — an estimated $17.6M sold.

McElhenny Sheffield Capital Management first reported a position in IHE in Q2 2024 and held it in 2 quarters. The position peaked at $18.9M in Q2 2024. 50 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • McElhenny Sheffield Capital Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • McElhenny Sheffield Capital Management sold 202,612 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $17.6M.
  • McElhenny Sheffield Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2024 and held it in 2 quarters.
  • McElhenny Sheffield Capital Management's iShares US Pharmaceuticals ETF position peaked at $18.9M in Q2 2024.
  • 50 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on McElhenny Sheffield Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.